Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
3
×
boulder/denver blog main
boulder/denver top stories
cancer
3
×
clinical trials
detroit blog main
detroit top stories
indiana blog main
3
×
indiana top stories
3
×
life sciences
merck
3
×
national
national blog main
national top stories
new york blog main
new york top stories
pembrolizumab
3
×
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
biotech
blueprint medicines
cancer immunotherapy
eli lilly
fda
gene therapy
medicare
migraine
nivolumab
abbvie
What
bio
companies
drug
new
roundup
approval
approved
arena’s
biogen’s
biopharmaceutical
bounty
cancer
cig
comeback
convo
corner
deals
deeper
delivered
dna
earlier
expressing
failures
fda
fingerprint
genetic
going
ipo
life
littered
little
matter
medicine
moderna’s
nash
nd
news
number
oks
price
Language
Current search:
merck
×
pembrolizumab
×
" indiana top stories "
×
" boston top stories "
×
" indiana blog main "
×
cancer
×
@xconomy.com
5 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More
@xconomy.com
5 years ago
Genetic Medicine: FDA OKs 2nd Cancer Drug that Targets DNA, not Tissues
@xconomy.com
5 years ago
Bio Roundup: Moderna’s IPO, Arena’s Comeback, E-Cig Survey & More